$Taysha Gene Therapies, Inc.(T

TSHA

11-04 23:20

USTaysha Gene Therapies, Inc.

Side	Price \| Filled	Realized P&L
Sell Close	4.38 800	+171.73% Closed

Taysha Gene Therapies, Inc.

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
11-05
Trade Feed Decoder
This TSHA trade demonstrates a high-conviction exit with exceptional realized gains (+171.73%) at $4.38. The biotech sector's inherent volatility suggests strategic timing around potential catalysts like clinical trial updates or sector rotation. While the percentage gain is impressive, the absolute exit price near 52-week lows (current range: $2.50-$5.50) implies possible early-stage speculation transformed into profit-taking. The trade aligns with momentum strategies in development-phase biopharma, where asymmetric risk/reward profiles demand precise exit discipline. However, the contrast between percentage returns and price level highlights the importance of entry timing in high-beta stocks. For retail investors, this underscores both the potential rewards and extreme risk management required when trading pre-revenue biotech equities.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":496628319540112,"tweetId":"496628319540112","gmtCreate":1762269666944,"gmtModify":1762269668979,"author":{"id":4093059716761930,"idStr":"4093059716761930","authorId":4093059716761930,"authorIdStr":"4093059716761930","name":"Jason Thoh","avatar":"https://community-static.tradeup.com/news/59bd64e94d037c3783c62510f3111e22","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.13","exceedPercentage":"80.33%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":85,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":85,"starInvestorOrderShareNum":15,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":191.53,"showRor":true,"winRationPercentage":59.52381,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/TSHA\">$Taysha Gene Therapies, Inc.(TSHA)$&nbsp;</a><a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/TSHA\">$Taysha Gene Therapies, Inc.(TSHA)$&nbsp;</a><a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$Taysha Gene Therapies, Inc.(TSHA)$ @Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/496628319540112","repostId":0,"isVote":1,"tweetType":1,"viewCount":100,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["TSHA"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"4093059716761930","orderId":"41073723402489856","kind":"TRADE","symbol":"TSHA","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/TSHA\">$Taysha Gene Therapies, Inc.(TSHA)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/TSHA","symbolName":"Taysha Gene Therapies, Inc.","market":"US","action":"SELL","currency":"USD","symbolLogo":"","showFilledQuantity":true,"nameCN":"Taysha Gene Therapies, Inc.","orderType":"LMT","filledQuantityFinal":800,"avgFillPrice":4.38,"createTime":1762269617,"filledQuantity":"800","filledQuantityScale":"0","openFlag":false,"side":"DEBIT","contractMajorDescription":"Taysha Gene Therapies, Inc.","contractExtraDescription":"TSHA","legs":[],"completedFlag":true,"orderPnl":{"realizedPnlPercent":1.7173,"realizedPnlByAveragePercent":1.8546},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":17,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":496648229609872,"commentId":"496648229609872","gmtCreate":1762274431307,"gmtModify":1762274436017,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":496628319540112,"objectIdStr":"496628319540112","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"This TSHA trade demonstrates a high-conviction exit with exceptional realized gains (+171.73%) at $4.38. The biotech sector's inherent volatility suggests strategic timing around potential catalysts like clinical trial updates or sector rotation. While the percentage gain is impressive, the absolute exit price near 52-week lows (current range: $2.50-$5.50) implies possible early-stage speculation transformed into profit-taking. The trade aligns with momentum strategies in development-phase biopharma, where asymmetric risk/reward profiles demand precise exit discipline. However, the contrast between percentage returns and price level highlights the importance of entry timing in high-beta stocks. For retail investors, this underscores both the potential rewards and extreme risk management required when trading pre-revenue biotech equities.","text":"This TSHA trade demonstrates a high-conviction exit with exceptional realized gains (+171.73%) at $4.38. The biotech sector's inherent volatility suggests strategic timing around potential catalysts like clinical trial updates or sector rotation. While the percentage gain is impressive, the absolute exit price near 52-week lows (current range: $2.50-$5.50) implies possible early-stage speculation transformed into profit-taking. The trade aligns with momentum strategies in development-phase biopharma, where asymmetric risk/reward profiles demand precise exit discipline. However, the contrast between percentage returns and price level highlights the importance of entry timing in high-beta stocks. For retail investors, this underscores both the potential rewards and extreme risk management required when trading pre-revenue biotech equities.","html":"This TSHA trade demonstrates a high-conviction exit with exceptional realized gains (+171.73%) at $4.38. The biotech sector's inherent volatility suggests strategic timing around potential catalysts like clinical trial updates or sector rotation. While the percentage gain is impressive, the absolute exit price near 52-week lows (current range: $2.50-$5.50) implies possible early-stage speculation transformed into profit-taking. The trade aligns with momentum strategies in development-phase biopharma, where asymmetric risk/reward profiles demand precise exit discipline. However, the contrast between percentage returns and price level highlights the importance of entry timing in high-beta stocks. For retail investors, this underscores both the potential rewards and extreme risk management required when trading pre-revenue biotech equities.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/496628319540112"}